Recifercept for Achondroplasia

Christian Czech, PhD Senior Director, Head of Research /Pfizer

The latest information on Pfizer‘s pipeline for Recifercept, “a biologic medicine that targets mutated fibroblast growth factor Receptor 3 (FGFR3).”